Page last updated: 2024-10-26

3,3'-diindolylmethane and Leishmaniasis, Visceral

3,3'-diindolylmethane has been researched along with Leishmaniasis, Visceral in 1 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bharate, SB1
Bharate, JB1
Khan, SI1
Tekwani, BL1
Jacob, MR1
Mudududdla, R1
Yadav, RR1
Singh, B2
Sharma, PR1
Maity, S1
Khan, IA1
Vishwakarma, RA1

Other Studies

1 other study available for 3,3'-diindolylmethane and Leishmaniasis, Visceral

ArticleYear
Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.
    European journal of medicinal chemistry, 2013, Volume: 63

    Topics: Antiprotozoal Agents; Drug Discovery; Humans; Indoles; Inhibitory Concentration 50; Leishmania donov

2013